Cargando…

Parallel evolution of reduced cancer risk and tumor suppressor duplications in Xenarthra

The risk of developing cancer is correlated with body size and lifespan within species, but there is no correlation between cancer and either body size or lifespan between species indicating that large, long-lived species have evolved enhanced cancer protection mechanisms. Previously we showed that...

Descripción completa

Detalles Bibliográficos
Autores principales: Vazquez, Juan Manuel, Pena, Maria T, Muhammad, Baaqeyah, Kraft, Morgan, Adams, Linda B, Lynch, Vincent J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810328/
https://www.ncbi.nlm.nih.gov/pubmed/36480266
http://dx.doi.org/10.7554/eLife.82558
_version_ 1784863289415565312
author Vazquez, Juan Manuel
Pena, Maria T
Muhammad, Baaqeyah
Kraft, Morgan
Adams, Linda B
Lynch, Vincent J
author_facet Vazquez, Juan Manuel
Pena, Maria T
Muhammad, Baaqeyah
Kraft, Morgan
Adams, Linda B
Lynch, Vincent J
author_sort Vazquez, Juan Manuel
collection PubMed
description The risk of developing cancer is correlated with body size and lifespan within species, but there is no correlation between cancer and either body size or lifespan between species indicating that large, long-lived species have evolved enhanced cancer protection mechanisms. Previously we showed that several large bodied Afrotherian lineages evolved reduced intrinsic cancer risk, particularly elephants and their extinct relatives (Proboscideans), coincident with pervasive duplication of tumor suppressor genes (Vazquez and Lynch, 2021). Unexpectedly, we also found that Xenarthrans (sloths, armadillos, and anteaters) evolved very low intrinsic cancer risk. Here, we show that: (1) several Xenarthran lineages independently evolved large bodies, long lifespans, and reduced intrinsic cancer risk; (2) the reduced cancer risk in the stem lineages of Xenarthra and Pilosa coincided with bursts of tumor suppressor gene duplications; (3) cells from sloths proliferate extremely slowly while Xenarthran cells induce apoptosis at very low doses of DNA damaging agents; and (4) the prevalence of cancer is extremely low Xenarthrans, and cancer is nearly absent from armadillos. These data implicate the duplication of tumor suppressor genes in the evolution of remarkably large body sizes and decreased cancer risk in Xenarthrans and suggest they are a remarkably cancer-resistant group of mammals.
format Online
Article
Text
id pubmed-9810328
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-98103282023-01-04 Parallel evolution of reduced cancer risk and tumor suppressor duplications in Xenarthra Vazquez, Juan Manuel Pena, Maria T Muhammad, Baaqeyah Kraft, Morgan Adams, Linda B Lynch, Vincent J eLife Cancer Biology The risk of developing cancer is correlated with body size and lifespan within species, but there is no correlation between cancer and either body size or lifespan between species indicating that large, long-lived species have evolved enhanced cancer protection mechanisms. Previously we showed that several large bodied Afrotherian lineages evolved reduced intrinsic cancer risk, particularly elephants and their extinct relatives (Proboscideans), coincident with pervasive duplication of tumor suppressor genes (Vazquez and Lynch, 2021). Unexpectedly, we also found that Xenarthrans (sloths, armadillos, and anteaters) evolved very low intrinsic cancer risk. Here, we show that: (1) several Xenarthran lineages independently evolved large bodies, long lifespans, and reduced intrinsic cancer risk; (2) the reduced cancer risk in the stem lineages of Xenarthra and Pilosa coincided with bursts of tumor suppressor gene duplications; (3) cells from sloths proliferate extremely slowly while Xenarthran cells induce apoptosis at very low doses of DNA damaging agents; and (4) the prevalence of cancer is extremely low Xenarthrans, and cancer is nearly absent from armadillos. These data implicate the duplication of tumor suppressor genes in the evolution of remarkably large body sizes and decreased cancer risk in Xenarthrans and suggest they are a remarkably cancer-resistant group of mammals. eLife Sciences Publications, Ltd 2022-12-08 /pmc/articles/PMC9810328/ /pubmed/36480266 http://dx.doi.org/10.7554/eLife.82558 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication (https://creativecommons.org/publicdomain/zero/1.0/) .
spellingShingle Cancer Biology
Vazquez, Juan Manuel
Pena, Maria T
Muhammad, Baaqeyah
Kraft, Morgan
Adams, Linda B
Lynch, Vincent J
Parallel evolution of reduced cancer risk and tumor suppressor duplications in Xenarthra
title Parallel evolution of reduced cancer risk and tumor suppressor duplications in Xenarthra
title_full Parallel evolution of reduced cancer risk and tumor suppressor duplications in Xenarthra
title_fullStr Parallel evolution of reduced cancer risk and tumor suppressor duplications in Xenarthra
title_full_unstemmed Parallel evolution of reduced cancer risk and tumor suppressor duplications in Xenarthra
title_short Parallel evolution of reduced cancer risk and tumor suppressor duplications in Xenarthra
title_sort parallel evolution of reduced cancer risk and tumor suppressor duplications in xenarthra
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810328/
https://www.ncbi.nlm.nih.gov/pubmed/36480266
http://dx.doi.org/10.7554/eLife.82558
work_keys_str_mv AT vazquezjuanmanuel parallelevolutionofreducedcancerriskandtumorsuppressorduplicationsinxenarthra
AT penamariat parallelevolutionofreducedcancerriskandtumorsuppressorduplicationsinxenarthra
AT muhammadbaaqeyah parallelevolutionofreducedcancerriskandtumorsuppressorduplicationsinxenarthra
AT kraftmorgan parallelevolutionofreducedcancerriskandtumorsuppressorduplicationsinxenarthra
AT adamslindab parallelevolutionofreducedcancerriskandtumorsuppressorduplicationsinxenarthra
AT lynchvincentj parallelevolutionofreducedcancerriskandtumorsuppressorduplicationsinxenarthra